Jiangsu Sinopep-Allsino Biopharmaceutical News

Nootech Investor Relations Activity Record Form (2024-004)

Oct 24 17:52

Nootai Biotech: Notice on the receipt by the company and one of the actual controllers of the case filing notice from the China Securities Regulatory Commission

Oct 24 00:00

Nootech: Supervisory Board Rules of Procedure

Oct 23 00:00

Nootech: Shareholders\' Meeting Rules of Procedure

Oct 23 00:00

Nootech: Articles of Association

Oct 23 00:00

Nootech Biotech: Announcement of Resolutions of the 20th Meeting of the 3rd Supervisory Board

Oct 23 00:00

Nortel Biotech: Announcement on Renewal of Accounting Firm

Oct 23 00:00

Nootai Biotech: Announcement on holding the 2024 semi-annual and third quarter results briefing

Oct 17 00:00

Nootech: Announcement on holding the 2024 semi-annual and third quarter results briefing

Oct 17 00:00

Nootech Biotech: Notice on Voluntary Disclosure of Compound Picosulfate Granules to Obtain Drug Registration Certificates

Oct 15 00:00

Reply to “Jiangsu Nuotai Aosainuo Biopharmaceutical Co., Ltd. Inquiry Letter on Abnormal Fluctuations in Stock Trading”

Oct 10 00:00

Nootech: Announcement on Abnormal Fluctuations in Stock Trading

Oct 10 00:00

Nootech Biotech: Nanjing Securities\'s inspection opinions on the resignation of the chairman of Nootech Biotech\'s Supervisory Board, the by-election of employee representative supervisors, and the addition of certified core technicians

Oct 8 00:00

Nootech: Nootai Biotech: Announcement of Resolutions of the 19th Meeting of the 3rd Board of Supervisors

Oct 8 00:00

Nootech Biotech: Announcement of Resolutions of the 19th Meeting of the 3rd Board of Supervisors

Oct 8 00:00

Nootai Biotech: Notice on Voluntary Disclosure of Oseltamivir Phosphate Suspension Obtaining a Drug Registration Certificate

Sep 26 00:00

Nootech Biotech: Notice on Voluntary Disclosure of Oseltamivir Phosphate Suspension Obtaining a Drug Registration Certificate

Sep 26 00:00

Nordtech Biotech Investor Relations Activity Record Form (2024-003)

Sep 2 16:04

Nanjing Securities Co., Ltd.\'s 2024 semi-annual continuous supervision and follow-up report on Jiangsu Nuotai Aosainuo Biopharmaceutical Co., Ltd.

Aug 28 00:00

Jiangsu Sinopep-Allsino Biopharmaceutical: Special report on the use and placement of funds raised during the first half of 2024.

Aug 23 00:00